Peritia Welcomes Michael A. Griffith as New Chief Executive Officer to Drive Growth
In a significant move for the company, Peritia has named Michael A. Griffith as its new Chief Executive Officer. This appointment marks a vital step in the firm’s efforts to bolster its position in the biopharmaceutical and medtech consulting sectors. Griffith brings over 25 years of experience in building and leading pharmaceutical services organizations, making him an ideal fit for the role as Peritia looks to accelerate its growth trajectory.
Prior to joining Peritia, Griffith was the founder and CEO of Amplity Health, a notable global organization that specializes in contractual medical and commercial services across 40 countries. His vast experience includes serving as an Operating Partner at Altamont Capital Partners, where he directed investments in biopharmaceutical outsourcing ventures, as well as being at the helm of the Commercial Division of inVentiv Health, a leader in biopharmaceutical outsourcing services.
Griffith’s impressive career also includes leadership roles with respected companies such as ChiRex, Aptuit, and Laureate Biopharma, which have established themselves as front-runners in contract drug development and manufacturing. He has also shared his insights and expertise through service on boards with organizations like Repligen Corporation, further reflecting his active involvement in the life sciences realm. Notably, Griffith earned his Master of Management from the prestigious Kellogg School of Management at Northwestern University.
In a statement reflecting on his new role, Griffith highlighted the burgeoning landscape of biopharma and medtech innovation funding, asserting that “Peritia is precisely the type of platform the market requires,” one which integrates scientific acumen, strategic advisory, and robust operational capabilities. This strategic vision is underpinned by the company's impressive track record, having conducted over 1,100 client engagements across 20 countries in just the past five years.
With Griffith’s leadership, Peritia aims to harness its established foundation to propel further growth. The company’s mission is to become a reliable partner for innovators in biotech, pharmaceuticals, and medtech, particularly those seeking guidance through the complexities of clinical development and health economics.
Griffith’s entry as CEO coincides with Peritia's recent rebranding initiative, which unified its previously separate entities - BioBridges, CHEORS, and Monitorforhire - under one cohesive platform. This consolidation enhances the company's ability to provide integrated services covering corporate and product strategy, operational execution, as well as value, evidence, and access.
His proven ability to cultivate high-performance cultures within life sciences service organizations positions him effectively to steer Peritia's mission of guiding life sciences organizations throughout their journey from concept to commercialization.
For more media inquiries or to understand how Peritia can assist your organization, feel free to reach out at [email protected] or visit www.peritia.com for further details. You can also follow Peritia on their LinkedIn page at https://www.linkedin.com/company/peritiaholdings.
About Peritia: Established as a global leader in biopharmaceutical and medtech consulting, Peritia excels in clinical development and the generation of value and evidence. The company is dedicated to pairing premier talent with life sciences organizations to expedite the delivery of innovations from conceptualization to patient care efficiently and effectively. Over the last five years, Peritia has successfully completed more than 1,100 engagements for 335 clients worldwide, evidencing its strong commitment to advancing the health sector.
Peritia a8pea8cb iea8lt a0cte fe 6a8,
Prior to joining Peritia, Griffith was the founder and CEO of Amplity Health, a notable global organization that specializes in contractual medical and commercial services across 40 countries. His vast experience includes serving as an Operating Partner at Altamont Capital Partners, where he directed investments in biopharmaceutical outsourcing ventures, as well as being at the helm of the Commercial Division of inVentiv Health, a leader in biopharmaceutical outsourcing services.
Griffith’s impressive career also includes leadership roles with respected companies such as ChiRex, Aptuit, and Laureate Biopharma, which have established themselves as front-runners in contract drug development and manufacturing. He has also shared his insights and expertise through service on boards with organizations like Repligen Corporation, further reflecting his active involvement in the life sciences realm. Notably, Griffith earned his Master of Management from the prestigious Kellogg School of Management at Northwestern University.
In a statement reflecting on his new role, Griffith highlighted the burgeoning landscape of biopharma and medtech innovation funding, asserting that “Peritia is precisely the type of platform the market requires,” one which integrates scientific acumen, strategic advisory, and robust operational capabilities. This strategic vision is underpinned by the company's impressive track record, having conducted over 1,100 client engagements across 20 countries in just the past five years.
With Griffith’s leadership, Peritia aims to harness its established foundation to propel further growth. The company’s mission is to become a reliable partner for innovators in biotech, pharmaceuticals, and medtech, particularly those seeking guidance through the complexities of clinical development and health economics.
Griffith’s entry as CEO coincides with Peritia's recent rebranding initiative, which unified its previously separate entities - BioBridges, CHEORS, and Monitorforhire - under one cohesive platform. This consolidation enhances the company's ability to provide integrated services covering corporate and product strategy, operational execution, as well as value, evidence, and access.
His proven ability to cultivate high-performance cultures within life sciences service organizations positions him effectively to steer Peritia's mission of guiding life sciences organizations throughout their journey from concept to commercialization.
For more media inquiries or to understand how Peritia can assist your organization, feel free to reach out at [email protected] or visit www.peritia.com for further details. You can also follow Peritia on their LinkedIn page at https://www.linkedin.com/company/peritiaholdings.
About Peritia: Established as a global leader in biopharmaceutical and medtech consulting, Peritia excels in clinical development and the generation of value and evidence. The company is dedicated to pairing premier talent with life sciences organizations to expedite the delivery of innovations from conceptualization to patient care efficiently and effectively. Over the last five years, Peritia has successfully completed more than 1,100 engagements for 335 clients worldwide, evidencing its strong commitment to advancing the health sector.
Peritia a8pea8cb iea8lt a0cte fe 6a8,
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.